The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation

European Journal of Immunology

Volumn 45, Issue 9, 2015, Pages 2446-2456

  Wensveen, Felix M ^a,b   Valentić, Sonja ^a   Šestan, Marko ^a   Turk Wensveen, Tamara ^c   Polić, Bojan ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c KBC RIJEKA   (Croatia)

Author keywords

Adiponectin; Adipose tissue; Diabetes mellitus type 2; IFN ; Inflammation; Insulin resistance; Macrophages; NK cells; Obesity; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; CYTOKINE;

ADIPOCYTE; ADIPOSE TISSUE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL POLARITY; DIET INDUCED OBESITY; DISEASE COURSE; EOSINOPHIL; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INTRAABDOMINAL FAT; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; STRESS; TISSUE STRUCTURE; UPREGULATION; ANIMAL; BIOSYNTHESIS; CLASSIFICATION; COMPLICATION; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; IMMUNOLOGY; INSULIN RESISTANCE; METABOLISM; MOUSE; PATHOLOGY;

ADIPOCYTES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; KILLER CELLS, NATURAL; MACROPHAGES; MICE; OBESITY;

EID: 84940953781     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545502     Document Type: Review

References (95)

1. Stevens, G. A., Singh, G. M., Lu, Y., Danaei, G., Lin, J. K., Finucane, M. M., Bahalim, A. N. et al., National, regional, and global trends in adult overweight and obesity prevalences. Popul. Health Metr. 2012. 10: 22.
2. Johnson, A. R., Milner, J. J. and Makowski, L., The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol. Rev. 2012. 249: 218-238.
3. Rui, L., Yuan, M., Frantz, D., Shoelson, S. and White, M. F., SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 2002. 277: 42394-42398.
4. Nedergaard, J., Bengtsson, T. and Cannon, B., Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab. 2007. 293: E444-E452.
5. Ronti, T., Lupattelli, G. and Mannarino, E., The endocrine function of adipose tissue: an update. Clin. Endocrinol. (Oxf) 2006. 64: 355-365.
6. Sanchez-Gurmaches, J. and Guertin, D. A., Adipocytes arise from multiple lineages that are heterogeneously and dynamically distributed. Nat. Commun. 2014. 5: 4099.
7. Wensveen, F. M., Jelencic, V., Valentic, S., Sestan, M., Wensveen, T. T., Theurich, S., Glasner, A. et al., NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 2015. 16: 376-385.
8. Zhu, J., Yamane, H. and Paul, W. E., Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 2010. 28: 445-489.
9. Lumeng, C. N., Bodzin, J. L. and Saltiel, A. R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007. 117: 175-184.
10. Mauer, J., Chaurasia, B., Goldau, J., Vogt, M. C., Ruud, J., Nguyen, K. D., Theurich, S. et al., Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat. Immunol. 2014. 15: 423-430.
11. Wu, D., Molofsky, A. B., Liang, H. E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., Chawla, A. et al., Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011. 332: 243-247.
12. Molofsky, A. B., Nussbaum, J. C., Liang, H. E., Van Dyken, S. J., Cheng, L. E., Mohapatra, A., Chawla, A. et al., Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 2013. 210: 535-549.
13. Patsouris, D., Li, P. P., Thapar, D., Chapman, J., Olefsky, J. M. and Neels, J. G., Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 2008. 8: 301-309.
14. Schipper, H. S., Rakhshandehroo, M., van de Graaf, S. F., Venken, K., Koppen, A., Stienstra, R., Prop, S. et al., Natural killer T cells in adipose tissue prevent insulin resistance. J. Clin. Invest. 2012. 122: 3343-3354.
15. Mathis, D., Immunological goings-on in visceral adipose tissue. Cell Metab. 2013. 17: 851-859.
16. Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S., Fagarasan, S. et al., The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 2015. 16: 276-285.
17. Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C. et al., PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012. 486: 549-553.
18. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J. et al., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009. 15: 930-939.
19. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R. et al., Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009. 15: 921-929.
20. Ouchi, N., Parker, J. L., Lugus, J. J. and Walsh, K., Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011. 11: 85-97.
21. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y. et al., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001. 7: 941-946.
22. Barnes, M. A., Carson, M. J. and Nair, M. G., Non-traditional cytokines: how catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. Cytokine 2015. 72: 210-219.
23. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H. and Flier, J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006. 116: 3015-3025.
24. Liu, J., Divoux, A., Sun, J., Zhang, J., Clement, K., Glickman, J. N., Sukhova, G. K. et al., Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009. 15: 940-945.
25. Zuniga, L. A., Shen, W. J., Joyce-Shaikh, B., Pyatnova, E. A., Richards, A. G., Thom, C., Andrade, S. M. et al., IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J. Immunol. 2010. 185: 6947-6959.
26. Lynch, L., Nowak, M., Varghese, B., Clark, J., Hogan, A. E., Toxavidis, V., Balk, S. P. et al., Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 2012. 37: 574-587.
27. Ohmura, K., Ishimori, N., Ohmura, Y., Tokuhara, S., Nozawa, A., Horii, S., Andoh, Y. et al., Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler. Thromb. Vasc. Biol. 2010. 30: 193-199.
28. Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D. et al., Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ. Res. 2010. 107: 650-658.
29. Molofsky, A. B., Savage, A. K. and Locksley, R. M., Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity 2015. 42: 1005-1019.
30. Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N. and Girard, J. P., Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J. Immunol. 2012. 188: 3488-3495.
31. Hashiguchi, M., Kashiwakura, Y., Kojima, H., Kobayashi, A., Kanno, Y. and Kobata, T., IL-33 activates eosinophils of visceral adipose tissue both directly and via innate lymphoid cells. Eur. J. Immunol. 2015. 45: 876-885.
32. Brestoff, J. R., Kim, B. S., Saenz, S. A., Stine, R. R., Monticelli, L. A., Sonnenberg, G. F., Thome, J. J. et al., Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015. 519: 242-246.
33. Lee, M. W., Odegaard, J. I., Mukundan, L., Qiu, Y., Molofsky, A. B., Nussbaum, J. C., Yun, K. et al., Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 2015. 160: 74-87.
34. Talukdar, S., Oh da, Y., Bandyopadhyay, G., Li, D., Xu, J., McNelis, J., Lu, M. et al., Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 2012. 18: 1407-1412.
35. Tam, C. S., Viardot, A., Clement, K., Tordjman, J., Tonks, K., Greenfield, J. R., Campbell, L. V. et al., Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans. Diabetes 2010. 59: 2164-2170.
36. Jeffery, E., Church, C. D., Holtrup, B., Colman, L. and Rodeheffer, M. S., Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity. Nat. Cell Biol. 2015. 17: 376-385.
37. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., Kitazawa, S. et al., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006. 116: 1494-1505.
38. Amano, S. U., Cohen, J. L., Vangala, P., Tencerova, M., Nicoloro, S. M., Yawe, J. C., Shen, Y. et al., Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab. 2014. 19: 162-171.
39. Li, P., Oh da, Y., Bandyopadhyay, G., Lagakos, W. S., Talukdar, S., Osborn, O., Johnson, A. et al., LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat. Med. 2015. 21: 239-247.
40. Molofsky, A. B., Van Gool, F., Liang, H. E., Van Dyken, S. J., Nussbaum, J. C., Lee, J., Bluestone, J. A. et al., Interleukin-33 and interferon-gamma counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity 2015. 43: 161-174.
41. Wang, Q. A., Tao, C., Gupta, R. K. and Scherer, P. E., Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat. Med. 2013. 19: 1338-1344.
42. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. and Friedman, J. M., Positional cloning of the mouse obese gene and its human homologue. Nature 1994. 372: 425-432.
43. Banks, A. S., Davis, S. M., Bates, S. H. and Myers, M. G., Jr., Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 2000. 275: 14563-14572.
44. Moraes-Vieira, P. M., Larocca, R. A., Bassi, E. J., Peron, J. P., Andrade-Oliveira, V., Wasinski, F., Araujo, R. et al., Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur. J. Immunol. 2014. 44: 794-806.
45. La Cava, A. and Matarese, G., The weight of leptin in immunity. Nat. Rev. Immunol. 2004. 4: 371-379.
46. Papathanassoglou, E., El-Haschimi, K., Li, X. C., Matarese, G., Strom, T. and Mantzoros, C., Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J. Immunol. 2006. 176: 7745-7752.
47. Tian, Z., Sun, R., Wei, H. and Gao, B., Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem. Biophys. Res. Commun. 2002. 298: 297-302.
48. Lo, C. K., Lam, Q. L., Yang, M., Ko, K. H., Sun, L., Ma, R., Wang, S. et al., Leptin signaling protects NK cells from apoptosis during development in mouse bone marrow. Cell Mol. Immunol. 2009. 6: 353-360.
49. Haas, P., Straub, R. H., Bedoui, S. and Nave, H., Peripheral but not central leptin treatment increases numbers of circulating NK cells, granulocytes and specific monocyte subpopulations in non-endotoxaemic lean and obese LEW-rats. Regul. Pept. 2008. 151: 26-34.
50. Zietz, B., Buchler, C., Herfarth, H., Muller-Ladner, U., Spiegel, D., Scholmerich, J. and Schaffler, A., Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A→G promoter polymorphism. Diabetes Obes. Metab. 2005. 7: 570-578.
51. Eder, K., Baffy, N., Falus, A. and Fulop, A. K., The major inflammatory mediator interleukin-6 and obesity. Inflamm. Res. 2009. 58: 727-736.
52. Scheller, J., Chalaris, A., Schmidt-Arras, D. and Rose-John, S., The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 2011. 1813: 878-888.
53. Kraakman, M. J., Kammoun, H. L., Allen, T. L., Deswaerte, V., Henstridge, D. C., Estevez, E., Matthews, V. B. et al., Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance. Cell Metab. 2015. 21: 403-416.
54. Wallenius, V., Wallenius, K., Ahren, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C. et al., Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 2002. 8: 75-79.
55. Starr, M. E., Evers, B. M. and Saito, H., Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6. J. Gerontol. A Biol. Sci. Med. Sci. 2009. 64: 723-730.
56. Balistreri, C. R., Caruso, C. and Candore, G., The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm. 2010. 2010: 802078.
57. Koppaka, S., Kehlenbrink, S., Carey, M., Li, W., Sanchez, E., Lee, D. E., Lee, H. et al., Reduced adipose tissue macrophage content is associated with improved insulin sensitivity in thiazolidinedione-treated diabetic humans. Diabetes 2013. 62: 1843-1854.
58. van der Voort, R., van Lieshout, A. W., Toonen, L. W., Sloetjes, A. W., van den Berg, W. B., Figdor, C. G., Radstake, T. R. et al., Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis Rheum. 2005. 52: 1381-1391.
59. Kurki, E., Shi, J., Martonen, E., Finckenberg, P. and Mervaala, E., Distinct effects of calorie restriction on adipose tissue cytokine and angiogenesis profiles in obese and lean mice. Nutr. Metab. (Lond.) 2012. 9: 64.
60. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M. et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007. 56: 1761-1772.
61. Karpe, F., Dickmann, J. R. and Frayn, K. N., Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011. 60: 2441-2449.
62. Reaven, G. M., Hollenbeck, C., Jeng, C. Y., Wu, M. S. and Chen, Y. D., Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988. 37: 1020-1024.
63. Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S. et al., Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 2012. 18: 1279-1285.
64. Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T., Brickey, W. J. et al., Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011. 12: 408-415.
65. Charles, M. A., Fontbonne, A., Thibult, N., Claude, J. R., Warnet, J. M., Rosselin, G., Ducimetiere, P. et al., High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study. Am. J. Epidemiol. 2001. 153: 292-298.
66. Byrne, C. D., Maison, P., Halsall, D., Martensz, N., Hales, C. N. and Wareham, N. J., Cross-sectional but not longitudinal associations between non-esterified fatty acid levels and glucose intolerance and other features of the metabolic syndrome. Diabet. Med. 1999. 16: 1007-1015.
67. Adams, J. M., 2nd, Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C. and Mandarino, L. J., Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004. 53: 25-31.
68. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S. et al., A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012. 490: 55-60.
69. Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergstrom, G., Behre, C. J., Fagerberg, B., Nielsen, J. et al., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013. 498: 99-103.
70. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M. and Burcelin, R., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008. 57: 1470-1481.
71. Ghanim, H., Abuaysheh, S., Sia, C. L., Korzeniewski, K., Chaudhuri, A., Fernandez-Real, J. M. and Dandona, P., Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 2009. 32: 2281-2287.
72. Pussinen, P. J., Havulinna, A. S., Lehto, M., Sundvall, J. and Salomaa, V., Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011. 34: 392-397.
73. Goldszmid, R. S., Caspar, P., Rivollier, A., White, S., Dzutsev, A., Hieny, S., Kelsall, B. et al., NK cell-derived interferon-gamma orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 2012. 36: 1047-1059.
74. Wong, N., Fam, B. C., Cempako, G. R., Steinberg, G. R., Walder, K., Kay, T. W., Proietto, J. et al., Deficiency in interferon-gamma results in reduced body weight and better glucose tolerance in mice. Endocrinology 2011. 152: 3690-3699.
75. Rocha, V. Z., Folco, E. J., Sukhova, G., Shimizu, K., Gotsman, I., Vernon, A. H. and Libby, P., Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 2008. 103: 467-476.
76. O'Rourke, R. W., White, A. E., Metcalf, M. D., Winters, B. R., Diggs, B. S., Zhu, X. and Marks, D. L., Systemic inflammation and insulin sensitivity in obese IFN-gamma knockout mice. Metabolism 2012. 61: 1152-1161.
77. Lanier, L. L., Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008. 9: 495-502.
78. Dungan, L. S., McGuinness, N. C., Boon, L., Lynch, M. A. and Mills, K. H., Innate IFN-gamma promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages. Eur. J. Immunol. 2014. 44: 2903-2917.
79. Ye, J., Gao, Z., Yin, J. and He, Q., Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 2007. 293: E1118-E1128.
80. Khan, T., Muise, E. S., Iyengar, P., Wang, Z. V., Chandalia, M., Abate, N., Zhang, B. B. et al., Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell Biol. 2009. 29: 1575-1591.
81. O'Rourke, R. W., Meyer, K. A., Neeley, C. K., Gaston, G. D., Sekhri, P., Szumowski, M., Zamarron, B. et al., Systemic NK cell ablation attenuates intra-abdominal adipose tissue macrophage infiltration in murine obesity. Obesity (Silver Spring) 2014. 22: 2109-2114.
82. Huebner, L., Engeli, S., Wrann, C. D., Goudeva, L., Laue, T. and Kielstein, H., Human NK cell subset functions are differentially affected by adipokines. PLoS One 2013. 8: e75703.
83. Wu, L., Parekh, V. V., Gabriel, C. L., Bracy, D. P., Marks-Shulman, P. A., Tamboli, R. A., Kim, S. et al., Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc. Natl. Acad. Sci. USA 2012. 109: E1143-E1152.
84. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M. et al., CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009. 15: 914-920.
85. Donath, M. Y. and Shoelson, S. E., Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011. 11: 98-107.
86. Mothe-Satney, I., Filloux, C., Amghar, H., Pons, C., Bourlier, V., Galitzky, J., Grimaldi, P. A. et al., Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes 2012. 61: 2311-2319.
87. Vandanmagsar, B., Youm, Y. H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E. et al., The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011. 17: 179-188.
88. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L. and Ferrante, A. W., Jr., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003. 112: 1796-1808.
89. Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z. W., Long, J. M., Wynshaw-Boris, A. et al., IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005. 11: 191-198.
90. Han, M. S., Jung, D. Y., Morel, C., Lakhani, S. A., Kim, J. K., Flavell, R. A. and Davis, R. J., JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 2013. 339: 218-222.
91. Latz, E., Xiao, T. S. and Stutz, A., Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 2013. 13: 397-411.
92. Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P. and Bahouth, S. W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004. 145: 2273-2282.
93. Altintas, M. M., Azad, A., Nayer, B., Contreras, G., Zaias, J., Faul, C., Reiser, J. et al., Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J. Lipid Res. 2011. 52: 480-488.
94. Dregan, A., Charlton, J., Chowienczyk, P. and Gulliford, M. C., Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study. Circulation 2014. 130: 837-844.
95. Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L. et al., Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012. 55: 1577-1596.